Reducing use of triple therapy after percutaneous coronary intervention: Results from a hospital‐wide quality improvement initiative
Sign Up to like & getrecommendations! Published in 2022 at "Catheterization and Cardiovascular Interventions"
DOI: 10.1002/ccd.30412
Abstract: Trials have shown that for patients on oral anticoagulants (OAC), a short course of dual antiplatelet therapy (DAPT) with OAC reduces post‐percutaneous coronary intervention (PCI) bleeding without increasing ischemic events. Adoption of this strategy has… read more here.
Keywords: use triple; therapy; improvement initiative; percutaneous coronary ... See more keywords
ASO Author Reflections: Changes in Use of Neoadjuvant Chemotherapy Over Time—Highest Rates of Use Now in Triple-Negative and HER2+ Disease
Sign Up to like & getrecommendations! Published in 2018 at "Annals of Surgical Oncology"
DOI: 10.1245/s10434-018-7046-9
Abstract: Initially, neoadjuvant chemotherapy (NAC) was predominantly used in locally advanced disease. However, NAC is now considered for any patient who would be recommended adjuvant chemotherapy based on clinical and histological examination at diagnosis. NAC may… read more here.
Keywords: disease; her2 disease; neoadjuvant chemotherapy; use triple ... See more keywords